Detection Times for Meloxicam in Competition Horses

Newsdate: Thu, 12 May 2011 - 09:45 am
Location: LAUSANNE, Switzerland

The FEI has announced detection times for Meloxicam (veterinary formulation known as Metacam®), a non-steroidal anti-inflammatory drug (NSAID) used to relieve pain and inflammation in the equine athlete.

The findings of studies on the use of intravenously or orally administered Meloxicam show the urine and plasma (blood) detection time as 72 hours (1).

This is the first COX-2 inhibitor on the FEI List of Detection Times, which contains common medications administered out of competition and is listed on the FEI Clean Sport website.

“We are committed to providing the tools to assist our athletes to adhere to the FEI’s Equine Anti-Doping Rules, and will add further medication detection times over the coming 12 months,” explains Graeme Cooke, Director of Veterinary Department at the FEI.

Meloxicam (Metacam®) is developed by Boehringer-Ingelheim.

About the Author

Flossie Sellers

As an animal lover since childhood, Flossie was delighted when Mark, the CEO and developer of EquiMed asked her to join his team of contributors.

She enrolled in My Horse University at Michigan State and completed a number of courses in everything related to horse health, nutrition, diseases and conditions, medications, hoof and dental care, barn safety, and first aid.

Staying  up-to-date on the latest developments in horse care and equine health is now a habit, and she enjoys sharing a wealth of information with horse owners everywhere..